CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Cannabis Bioscience International Holdings, Inc.
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026
- Market cap
- $2.33M
- P/E (TTM)
- –
- Dividend yield
- –
Cannabis Bioscience International Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Trials [Member] | $11.20K | $40.90K | $24.14K | $34.63K | $14.93K | $73.78K | $178.39K | $63.30K | $35.60K | $52.01K | $62.96K | $36.93K | 100.0% | -25.0% |
| Merchandise [Member] | $5 | $72 | $61 | $323 | $0 | $467 | $501 | $591 | $810 | $1.43K | $1.53K | $20.67K | 0.0% | – |
| Seminar Fees [Member] | $0 | $291 | – | $0 | $0 | $0 | – | $0 | $0 | $1.98K | – | $0 | 0.0% | – |
| Consulting Fees [Member] | $0 | $12.00K | – | $0 | $0 | $0 | $0 | $11.97K | $0 | $8.33K | $8.33K | $8.33K | 0.0% | – |
| Royalties [Member] | – | – | – | – | – | $0 | – | – | – | $0 | – | – | – | – |
| Video Course Purchase [Member] | – | – | – | – | – | – | – | – | $0 | – | – | – | – | – |
| Royalty Income [Member] | – | – | – | – | – | – | – | – | $0 | – | – | – | – | – |
| Sales Of Product Income [Member] | – | – | – | – | – | – | – | – | $0 | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Cannabis Bioscience International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.